Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Biofrontera AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Biofrontera AG, Medical Devices Deals, 2012 to YTD 2018 10
Biofrontera AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Biofrontera AG, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Deutsche Balaton to Acquire 14% Stake in Biofrontera 12
Partnerships 13
Biofrontera Extends Its Agreement with Maruho 13
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 14
Licensing Agreements 15
Biofrontera Pharma Enters into Licensing Agreement with Louis Widmer 15
Biofrontera Enters Into Licensing Agreement With Pharma.MT For Ameluz 16
Equity Offering 17
Biofrontera Raises USD13 Million in Public Offering of ADS 17
Biofrontera Raises USD17 Million in Rights Offering of Shares 19
Biofrontera Secures USD22.2 Million in Financing 20
Biofrontera to Raise USD16.5 Million in Private Placement of Shares 21
Biofrontera Raises USD5 Million in Private Placement of Shares 22
Biofrontera Raises USD4 Million in Rights Offering of Shares 23
Biofrontera to Raise up to USD3.4 Million in Private Placement of Shares 24
Biofrontera Raises USD3.4 Million in Rights Offering of Shares 25
Biofrontera Completes Private Placement Of Shares For US$9.7 Million 26
Biofrontera Completes Rights Offering Of Shares For US$15 Million 27
Debt Offering 28
Biofrontera Raises USD5.5 Million in Private Placement of Debentures 28
Biofrontera Raises USD5.5 Million in Private Placement of Bonds Due 2020 29
Acquisition 30
Carsten Maschmeyer Acquires Additional 15.1% Stake In Biofrontera 30
Biofrontera AG – Key Competitors 31
Biofrontera AG – Key Employees 32
Biofrontera AG – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Oct 10, 2018: Biofrontera announces preliminary unaudited sales revenue for the first nine months of 2018 and increases revenue guidance 34
Sep 17, 2018: Biofrontera uses the long summer months to introduce daylight photodynamic therapy (PDT) with Ameluz in the EU 35
Aug 31, 2018: Biofrontera reports significant revenue growth for the first 6 months of 2018 36
Jul 05, 2018: Biofrontera: Sales revenue for Ameluz(R) doubled for the six-month period ended June 30, 2018 38
May 30, 2018: Biofrontera Announces First Quarter 2018 Financial Results 39
Apr 30, 2018: Biofrontera Announces Full Year 2017 Financial Results 41
Apr 12, 2018: Biofrontera announces preliminary unaudited sales revenues for the 1st Quarter 2018 44
Jan 22, 2018: Biofrontera Announces Preliminary Unaudited Full Year 2017 Revenue 45
Nov 27, 2017: Biofrontera Reports Financial Results for Third Quarter and First Nine Months of 2017 46
Nov 14, 2017: Biofrontera adjusts revenues and earnings forecast for the financial year 2017 48
Aug 31, 2017: Biofrontera Grows Revenues and Improves Financial Position in First Half 2017 49
Legal and Regulatory 51
Jul 12, 2018: Biofrontera: Biofrontera subsidiary files suit against DUSA Pharmaceuticals 51
Jul 11, 2018: DUSA pharmaceuticals files patent infringement suit against German drug maker Biofrontera 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
Biofrontera AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Biofrontera AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Biofrontera AG, Deals By Therapy Area, 2012 to YTD 2018 9
Biofrontera AG, Medical Devices Deals, 2012 to YTD 2018 10
Biofrontera AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Deutsche Balaton to Acquire 14% Stake in Biofrontera 12
Biofrontera Extends Its Agreement with Maruho 13
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 14
Biofrontera Pharma Enters into Licensing Agreement with Louis Widmer 15
Biofrontera Enters Into Licensing Agreement With Pharma.MT For Ameluz 16
Biofrontera Raises USD13 Million in Public Offering of ADS 17
Biofrontera Raises USD17 Million in Rights Offering of Shares 19
Biofrontera Secures USD22.2 Million in Financing 20
Biofrontera to Raise USD16.5 Million in Private Placement of Shares 21
Biofrontera Raises USD5 Million in Private Placement of Shares 22
Biofrontera Raises USD4 Million in Rights Offering of Shares 23
Biofrontera to Raise up to USD3.4 Million in Private Placement of Shares 24
Biofrontera Raises USD3.4 Million in Rights Offering of Shares 25
Biofrontera Completes Private Placement Of Shares For US$9.7 Million 26
Biofrontera Completes Rights Offering Of Shares For US$15 Million 27
Biofrontera Raises USD5.5 Million in Private Placement of Debentures 28
Biofrontera Raises USD5.5 Million in Private Placement of Bonds Due 2020 29
Carsten Maschmeyer Acquires Additional 15.1% Stake In Biofrontera 30
Biofrontera AG, Key Competitors 31
Biofrontera AG, Key Employees 32
Biofrontera AG, Subsidiaries 33
List of Figures
Biofrontera AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Biofrontera AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Biofrontera AG, Medical Devices Deals, 2012 to YTD 2018 10